Wednesday, May 20, 2020

Thank you and farewell Dr Morag Young


Thank you Dr Morag Young for an informative presentation on Mineralocorticoid receptors - past, present and future. It was extremely well received with a resounding Zoom applause!

Dr Morag Young was previously head of Cardiovascular Endocrinology at Hudson Institute and has received numerous awards, grants and accolades for her outstanding work on MR biology and cardiovascular disease.

We wish Morag all the best in her new position as Head of the Cardiovascular Endocrinology group at the Baker Institute in the Preclinical and Drug Discovery Theme.

Dr Morag Young is the recent recipient of the Alice Baker and Eleanor Shaw Gender Equity Fellowship at the Baker Institute.

Morag undertook PhD studies at the Baker Institute with Professor John Funder investigating the pathophysiology of mineralocorticoid receptor (MR) signalling in the heart and vasculature. As a C.J. Martin postdoctoral scientist she trained with the late Prof Keith Parker, UT Southwestern Medical Centre, Dallas TX and developed transgenic mouse models lacking adrenal steroidogenesis and identified a new model of hypothalamic obesity. On returning to Australia and the Baker she then trained with Associate Professor Tim Cole to create novel transgenic mouse models for the MR.

Morag was recruited to Prince Henry’s Institute of Medical Research in 2002 by Professor Peter Fuller and served as cohead of the Steroid Receptor Biology Group and to establish a new research direction for cardiovascular endocrinology diseases.


She started her own research laboratory in 2005 and has identified novel mechanisms of MR action in cardiovascular disease that include cell selective pathways in macrophages, cardiomyocytes and endothelial cells.


Her most recent work identified a highly novel interaction of the MR with the molecular clock in the pathogenesis of cardiovascular disease and a new biology for MR signalling in monocytes/macrophages. New directions include the development of a tissue selective MR antagonist and validation of research outcomes in heart failure patients.


Morag has been funded by 8 NHMRC grants, four as CIA, NHF, philanthropic organisations and pharma.


Recognition of Morag’s standing as a leader of MR biology and cardiovascular disease is indicated by invitations for keynote lectures at leading international conferences each year, international departmental seminars and the award of the American Heart Association Best Basic Science Paper (2009).


Morag serves as Receiving Editor for The Journal of Endocrinology, The Journal of Molecular Endocrinology and The Journal of Steroid Biochemistry and Molecular Biology and is a Member of the Editorial Board for Endocrinology.


Morag was appointed to the US Endocrine Society Annual Meeting Steering Committee (2017-2020) and has worked to develop International Leadership Training as an outreach activities for the US Endocrine Society. She has trained 8 PhD students to completion and 20 honours students.


Morag has many ongoing productive collaborations with researchers within the Hudson, SCS and Monash Health and looks forward to continuing to work with her long standing colleagues.


We would like to take this opportunity to thank Morag and wish her all the best for her future research.








No comments:

Post a Comment